Press release
Global In Situ Hybridization Market Size to grow at a CAGR of 7.12% to reach USD 2,886.13 million by 2032, Evaluates DelveInsight
DelveInsight's "In Situ Hybridization Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key In Situ Hybridization companies actively working in the market.
To know more about why North America is leading the market growth in the In Situ Hybridization market, get a snapshot of the report In Situ Hybridization Market Trends
https://www.delveinsight.com/sample-request/in-situ-hybridization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
In Situ Hybridization Overview
An In Situ Hybridization is a biological preparation designed to protect against the influenza (flu) virus. It stimulates the body's immune system to produce antibodies that recognize and fight specific strains of the virus. Flu vaccines are typically updated each year to match circulating virus variants and are available in several forms, including inactivated (killed virus) and live attenuated (weakened virus) types. Annual vaccination is recommended for most individuals, especially high-risk groups such as young children, the elderly, and people with chronic health conditions, to reduce flu-related illness, hospitalization, and mortality.
DelveInsight Analysis: The in situ hybridization market size was valued at USD 1,673.55 million in 2024, is anticipated to grow at a CAGR of 7.12% from 2025 to 2032, reaching USD 2,886.13 million by 2032.
In Situ Hybridization Market Insights
Geographically, North America is expected to lead the in situ hybridization market in 2024, driven by the rising incidence of cancer and rare genetic disorders. ISH plays a crucial role in cancer research and diagnostics by enabling the identification of gene expression patterns and genetic abnormalities associated with malignancies, which supports market growth in the region. Additionally, the increasing volume of molecular diagnostic tests being performed further accelerates the expansion of the in situ hybridization market across North America.
To read more about the latest highlights related to In Situ Hybridization, get a snapshot of the key highlights entailed in the In Situ Hybridization Insights
https://www.delveinsight.com/report-store/in-situ-hybridization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the In Situ Hybridization Market Report
• In January 2024, Biocare Medical, LLC, a US-based tissue diagnostic company announced its collaboration with Molecular Instruments to develop automated bioimaging. This partnership combines Biocare Medical's proficiency in automated bioimaging systems with MI's array of advanced HCRTM Products, establishing a new benchmark in automated in situ hybridization (ISH) and immunohistochemistry (IHC).
• In May 2023, Bio-Techne, a US-based life sciences company launched Advanced Cell Diagnostics (ACD)-branded RNAscopeTM in situ hybridization (ISH). RNAscope HiPlex12 Flex Kit allows for the visualization of highly multiplexed RNA biomarkers utilizing the Hyperion XTi or previous versions of the Hyperion Imaging System. This cutting-edge system facilitates the simultaneous detection and precise quantification of over 40 biomarkers from any tissue sample in a single imaging step, employing Imaging Mass Cytometry.
• In November 2022, Biocare Medical, LLC completed the acquisition of Empire Genomics, a molecular biomarkers company pioneering in cancer research and diagnostics. This acquisition serves to complement our extensive portfolio of IHC antibodies, comprehensive molecular menu, and sophisticated automation platform.
• Thus, owing to such developments in the market, rapid growth will be observed in the In Situ Hybridization market during the forecast period
Key Players in the In Situ Hybridization Market
Some of the key market players operating in the In Situ Hybridization market include- Abbott Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., PerkinElmer Inc., Sysmex Corporation, Biocare Medical, LLC, Genemed Biotechnologies, Inc., NeoGenomics Laboratories, Advanced Cell Diagnostics, Inc., BioView, Bio-Rad Laboratories, Inc., Bio-Techne, QIAGEN, BioGenex, ZYTOVISION GmbH, Promega Corporation, Illumina, Inc., Danaher Corporation, and others.
Which MedTech key players in the In Situ Hybridization market are set to emerge as the trendsetter explore @ Key In Situ Hybridization Companies
https://www.delveinsight.com/sample-request/in-situ-hybridization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the In Situ Hybridization Market Landscape
In cellular biology and neuroscience, researchers rely on fluorescence in situ hybridization (FISH) to examine gene expression, localization, and activity within cells and tissues. This technique enables the visualization of specific genes or RNA molecules across various cell types, including neuronal and glial cells. By analyzing spatial gene expression patterns, scientists gain crucial insights into brain development, function, and the mechanisms underlying neurological disorders. FISH also supports the diagnosis of genetic conditions by highlighting chromosomal regions or genes linked to these diseases.
As a result, the broad applications of FISH are expected to strengthen segment growth and drive the overall in situ hybridization market during the forecast period.
Scope of the In Situ Hybridization Market Report
• Coverage: Global
• Study Period: 2022-2032
• In Situ Hybridization Market Segmentation By Product Type: Instruments, Reagents & Kits, and Software
• In Situ Hybridization Market Segmentation By Technology: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH), and Others
• In Situ Hybridization Market Segmentation By Application: Cancer Diagnosis, Genetic Diseases, Infectious Diseases, and Others
• In Situ Hybridization Market Segmentation By End-User: Hospitals and Clinics, Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others
• In Situ Hybridization Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key In Situ Hybridization Companies: Abbott Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., PerkinElmer Inc., Sysmex Corporation, Biocare Medical, LLC, Genemed Biotechnologies, Inc., NeoGenomics Laboratories, Advanced Cell Diagnostics, Inc., BioView, Bio-Rad Laboratories, Inc., Bio-Techne, QIAGEN, BioGenex, ZYTOVISION GmbH, Promega Corporation, Illumina, Inc., Danaher Corporation, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the In Situ Hybridization market will grow by 2032? Click to get a snapshot of the In Situ Hybridization Market Analysis
https://www.delveinsight.com/sample-request/in-situ-hybridization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global In Situ Hybridization Market Size to grow at a CAGR of 7.12% to reach USD 2,886.13 million by 2032, Evaluates DelveInsight here
News-ID: 4273916 • Views: …
More Releases from DelveInsight Business Research
Sepsis Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sepsis pipeline constitutes 25+ key companies continuously working towards developing 30+ Sepsis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Sepsis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sepsis Market.
The Sepsis Pipeline report embraces in-depth…
Actinic Keratosis Market to Experience Notable Growth in Forecast Span by 2034, …
The Actinic Keratosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Actinic Keratosis pipeline products will significantly revolutionize the Actinic Keratosis market dynamics.
DelveInsight's "Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United…
Cystinosis Market Insights Highlight Expanding Outlook Till 2032, DelveInsight E …
The Cystinosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cystinosis pipeline products will significantly revolutionize the Cystinosis market dynamics.
DelveInsight's "Cystinosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cystinosis, historical and forecasted epidemiology as well as the Cystinosis market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Allergic Rhinitis Market to Evolve Rapidly Over the Next Decade by 2034, DelveIn …
DelveInsight's "Allergic Rhinitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Allergic Rhinitis, historical and forecasted epidemiology as well as the Allergic Rhinitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Allergic Rhinitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Allergic Rhinitis Market Forecast
https://www.delveinsight.com/sample-request/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts…
More Releases for Situ
Driving In Situ Hybridization Market Growth in 2025: The Role of The Surging Rol …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
In Situ Hybridization Market Size Growth Forecast: What to Expect by 2025?
The market size for in situ hybridization has seen robust growth in the past few years. It is predicted to increase from $1.68 billion in 2024 to $1.81 billion in 2025, with a compound annual growth rate…
The Surging Role Of In-Situ Hybridization In Tackling Infectious Diseases: Key F …
The In Situ Hybridization Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected In Situ Hybridization Market Size During the Forecast Period?
The In Situ Hybridization Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025…
Situ Hybridization Market Size, Share, Growth Report 2033
The new report published by The Business Research Company, titled In Situ Hybridization Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the in situ hybridization market size has grown strongly in recent years. It will grow from…
How big is In-Situ Hybridization (ISH) Market?
A new Report by DataM Intelligence, titled "In-Situ Hybridization (ISH) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the In-Situ Hybridization (ISH) market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The In-Situ Hybridization…
Global In Situ Hybridization ISH Market By Technology: Fluorescent In Situ Hybri …
According to the latest research by SkyQuest Technology, the Global in situ hybridization ish market was valued at US$ 1.92 billion in 2021, and it is expected to reach a value of US$ 2.42 billion by 2028, at a CAGR of more than 9.2% over the forecast period of 2022 - 2028. The research provides up-to-date In Situ Hybridization ISH market analysis of the current market landscape, latest trends, drivers,…
In-Situ Hybridization Market 2021 | Detailed Report
Global In-Situ Hybridization Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures)…
